- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 285.63M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 285.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 273.61M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $0 |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $3.46M |
| Capex | Q1 2026 · Mar 31, 2026 | $43.57M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $255.1M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$118.9M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$7.24M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.11B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.11B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $73.92M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $73.22M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $92.39M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $226.45M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $447.86M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$180.24M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $182.65M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.93B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $8.65B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $10.45B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $10.25B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.16B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.33B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $10.39B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $10.56B |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $13.08B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.40 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.65 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.40 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.65 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $47.49M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $51.82M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$225.38M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$12.52M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $199.69M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $302.38M |
| Revenue | Q1 2026 · Mar 31, 2026 | $185.21M |
| Revenue | Q1 2026 · Mar 31, 2025 | $384.88M |